Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
Tomonori Tanei(Methodist Hospital), Jenny C. Chang(Cornell University)
Cited by 64
Related Papers
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
|Breast Cancer Research|2012|259
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
|Breast Cancer Research|2015|221
Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
|Stem Cells|2014|118